Merck Drug Fosamax Claimed To Be Defective By Woman
In what is a serious product liability action, Drug maker Merck has just been sued by a Mississippi woman who took Fosamax, a drug that treats osteoporosis. The injured woman contends that Merck knew the drug was dangerous and defective when it went to market. To make matters worse, it's alleged Merck bribed the doctors to give the drug to patients and that the drug was marketed without regard to the well-being of the patient and without regard to patient being injured.
The drug in question, Fosamax, is supposed to treat people who have brittle bones. In the case of the Plaintiff, the drug actually did the opposite, injuring the user and causing irreversible bone decay.
This is not the first product liability lawsuit involving Merck where the pharmaceutical giant has been sued for injuries caused by this drug. Back in August of this year, another woman sued Merck under similar circumstances. Plaintiffs in both suits argue that Fosamax is defective, detrimental to people and lacks suitable warning labels.
The injured Plaintiffs specifically allege that Fosamax actually induced an infection, causing the jaw bones to die and that the design of the drug is defective.
I represent people who have been injured by dangerous and defective drugs like Fosamax. If you or someone you care about has been injured by this drug, I am available for a free consultation. Please visit my website. www.samlevine.com.
